Skip to content
Open access

DNA nanotechnology in therapeutic modulation and bio-inspired systems for precision medicine

· Biomedical Engineering Communications · Vol 6, pp. 7 · 0 citations · 24 references

TL;DR

Using DNA nanostructures as “molecular calipers”, researchers employ Watson-Crick base-pairing principles to precisely define the inter-binding site distances, which allows for perfect topological matching.

Abstract

Nucleic acid nanotechnology, particularly DNA-based nanostructures, is fundamentally reshaping the paradigms of drug delivery and therapeutics, by leveraging their high programmability, precise self-assembly capabilities, and superior biocompatibility. Beyond constructing static frameworks with prescribed dimensions and geometries, such as tetrahedral DNA nanostructures (TDNs), DNA origami, and spherical nucleic acids (SNAs), these molecular entities can be engineered via dynamic sequence design to facilitate intelligent responsiveness to environmental stimuli [1, 2]. Such molecular-level engineering versatility positions DNA nanostructures as a pivotal conduit bridging fundamental biological insights and clinical precision medicine. As the field matures, DNA nanotechnology is demonstrating transformative potential in cancer immunotherapy, the modulation of intercellular communication, and the construction of engineered biomodels. Leveraging its digital programmability, it has evolved from simple carrier development into a sophisticated molecular engineering platform, enabling the quantitative modulation of complex biological processes with single-nucleotide precision. By utilizing DNA nanostructures as “molecular calipers”, researchers employ Watson-Crick base-pairing principles to precisely define the inter-binding site distances (e.g., 18–20 nm) [3, 4]. This allows for perfect topological matching

Read PDF

Similar papers

Aug 2026

Potentiating In Vivo Precision Cancer Therapy With Modularized Aptamer-Chemotherapeutics Conjugates Based on DNA Tiling-Mediated Structural Nanotechnology.

A tumor cell-targeting therapeutic agent-loaded nanoconjugate, AS1411-DNT-5-FU, is constructed, which exhibits significantly higher therapeutic outcomes than clinic free 5-FU in MCF-7 tumor-bearing mouse models without observable systemic toxicity.

Wei-Jun Wang, Jingting Wu, Yu-Xi Yang et al. · 0 citations
Review Open access Jul 2026

Precision chemical engineering of dendrimers for nucleic acid delivery

Future progress of dendrimers will be accelerated by more simplified and easily scalable synthetic processes, enhanced targeting to specific tissues and cells, as well as artificial intelligence-assisted design and optimization to posture dendrimers as a next-generation platform for nucleic acid delivery and precision...

Qianqian Ni, D. Tomalia, Jing Wu et al. · 1 citation
Review Jul 2026

Aptamer-carbon Nanotube Hybrids: Emerging Frontiers in Biomedical Diagnostics and Therapeutics.

Overall, aptamer-CNT hybrids hold immense promise as versatile, tunable, and multifunctional platforms that could fundamentally transform next-generation precision medicine and nanotherapeutic systems.

Rohit R. Bhosale, Sarika J. Patil, Satwashila S. Kadam et al. · 1 citation
Review Aug 2026

Progress of Framework Nucleic Acids in Tumor Diagnosis and Therapy.

This review summarizes the remarkable potential of Framework Nucleic Acids (FNAs) as an intelligent nanoplatform for tumor diagnosis and therapy and discusses the major challenges for clinical translation.

Mengting Liu, Tiantian Wu, Qifeng Zhang et al. · 0 citations
Review Jul 2026

Innate Immunity of Framework Nucleic Acids.

This Account reviews efforts to develop framework nucleic acids (FNAs) as a platform with modulable innate immunostimulation for biomedical applications in live cells and in vivo, and envision FNAs as intelligent tools for precision immunomodulation, bridging nanoscale design with immunological outcomes to advance pers...

Lin-Jie Guo, Fei Zhou, Ying Zhu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.